Wikidata

(Q95056331)

English

Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in Canada

clinical trial

In more languages

Statements

title
A Randomized, Observer-Blind, Dose-escalation Phase I/II Clinical Trial of Ad5-nCoV Vaccine in Healthy Adults From 18 to <85 Years of Age in Canada (English)
0 references
country
Canada
0 references
start time
May 2020
0 references
end time
March 2021
0 references
number of participants
696
0 references
minimum age
18 year
0 references
maximum age
84 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q95056331&oldid=2136171980"